

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.16913126 |
| 2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.94394665 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.89307864 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.89307864 |
| 5 | regulation of gamma-delta T cell activation (GO:0046643) | 4.77160386 |
| 6 | NIK/NF-kappaB signaling (GO:0038061) | 4.63209058 |
| 7 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.46271497 |
| 8 | cellular response to interferon-alpha (GO:0035457) | 4.31873333 |
| 9 | positive regulation of interferon-alpha production (GO:0032727) | 4.29613419 |
| 10 | response to type I interferon (GO:0034340) | 4.17470330 |
| 11 | negative regulation of viral genome replication (GO:0045071) | 4.12920011 |
| 12 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.12477205 |
| 13 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.11073292 |
| 14 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.11073292 |
| 15 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.11073292 |
| 16 | modulation by symbiont of host immune response (GO:0052553) | 4.11073292 |
| 17 | positive regulation by symbiont of host defense response (GO:0052509) | 4.11073292 |
| 18 | modulation by symbiont of host defense response (GO:0052031) | 4.11073292 |
| 19 | cellular response to type I interferon (GO:0071357) | 4.10465178 |
| 20 | type I interferon signaling pathway (GO:0060337) | 4.10465178 |
| 21 | regulation of interferon-alpha production (GO:0032647) | 4.08909678 |
| 22 | positive regulation of humoral immune response (GO:0002922) | 3.92472346 |
| 23 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.73731847 |
| 24 | detection of other organism (GO:0098543) | 3.68230768 |
| 25 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.67893019 |
| 26 | positive regulation of B cell differentiation (GO:0045579) | 3.64279339 |
| 27 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.61526321 |
| 28 | positive thymic T cell selection (GO:0045059) | 3.59598076 |
| 29 | detection of bacterium (GO:0016045) | 3.55898052 |
| 30 | response to muramyl dipeptide (GO:0032495) | 3.55481313 |
| 31 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.48938500 |
| 32 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.44022916 |
| 33 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.43851903 |
| 34 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.41249334 |
| 35 | I-kappaB phosphorylation (GO:0007252) | 3.40495272 |
| 36 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.39511994 |
| 37 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.33808766 |
| 38 | B cell receptor signaling pathway (GO:0050853) | 3.28739762 |
| 39 | macrophage activation involved in immune response (GO:0002281) | 3.27940039 |
| 40 | leukocyte aggregation (GO:0070486) | 3.27726748 |
| 41 | positive regulation of antigen processing and presentation (GO:0002579) | 3.25299530 |
| 42 | interferon-gamma secretion (GO:0072643) | 3.25020554 |
| 43 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.23592881 |
| 44 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.23305936 |
| 45 | cellular response to virus (GO:0098586) | 3.20800448 |
| 46 | regulation of type 2 immune response (GO:0002828) | 3.18049075 |
| 47 | regulation of B cell differentiation (GO:0045577) | 3.17439559 |
| 48 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.15881136 |
| 49 | mature B cell differentiation (GO:0002335) | 3.13861155 |
| 50 | negative regulation of T cell mediated immunity (GO:0002710) | 3.13547610 |
| 51 | positive regulation of interferon-beta production (GO:0032728) | 3.13077360 |
| 52 | response to protozoan (GO:0001562) | 3.09921539 |
| 53 | detection of external biotic stimulus (GO:0098581) | 3.09852587 |
| 54 | response to peptidoglycan (GO:0032494) | 3.09180257 |
| 55 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.08134579 |
| 56 | cellular response to exogenous dsRNA (GO:0071360) | 3.07728487 |
| 57 | detection of molecule of bacterial origin (GO:0032490) | 3.05898569 |
| 58 | negative thymic T cell selection (GO:0045060) | 3.05368599 |
| 59 | myeloid dendritic cell differentiation (GO:0043011) | 2.98081308 |
| 60 | positive regulation of interleukin-12 production (GO:0032735) | 2.97064200 |
| 61 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.96121867 |
| 62 | response to interferon-beta (GO:0035456) | 2.95862906 |
| 63 | germinal center formation (GO:0002467) | 2.95808829 |
| 64 | immunoglobulin mediated immune response (GO:0016064) | 2.92846745 |
| 65 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.92802817 |
| 66 | negative regulation of cell killing (GO:0031342) | 2.92212247 |
| 67 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.92212247 |
| 68 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.91775944 |
| 69 | natural killer cell mediated immunity (GO:0002228) | 2.91775944 |
| 70 | defense response to virus (GO:0051607) | 2.91615305 |
| 71 | T cell migration (GO:0072678) | 2.91512331 |
| 72 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.91286734 |
| 73 | negative regulation of viral process (GO:0048525) | 2.90660949 |
| 74 | regulation of T cell tolerance induction (GO:0002664) | 2.90244259 |
| 75 | negative T cell selection (GO:0043383) | 2.89501856 |
| 76 | regulation of cholesterol storage (GO:0010885) | 2.87948494 |
| 77 | negative regulation of type 2 immune response (GO:0002829) | 2.87739312 |
| 78 | regulation of chronic inflammatory response (GO:0002676) | 2.84653678 |
| 79 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.84468361 |
| 80 | response to host immune response (GO:0052572) | 2.84468361 |
| 81 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.83727516 |
| 82 | response to interferon-alpha (GO:0035455) | 2.83717132 |
| 83 | positive regulation of interleukin-2 production (GO:0032743) | 2.83237496 |
| 84 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.82106429 |
| 85 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.81774075 |
| 86 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.81324179 |
| 87 | thymic T cell selection (GO:0045061) | 2.80252672 |
| 88 | negative regulation of interleukin-12 production (GO:0032695) | 2.79436622 |
| 89 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.79312391 |
| 90 | T-helper 1 type immune response (GO:0042088) | 2.79214467 |
| 91 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.78900980 |
| 92 | regulation of podosome assembly (GO:0071801) | 2.78286774 |
| 93 | regulation of viral genome replication (GO:0045069) | 2.78166106 |
| 94 | phospholipid homeostasis (GO:0055091) | 2.77740549 |
| 95 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.77722147 |
| 96 | regulation of chemokine biosynthetic process (GO:0045073) | 2.75875654 |
| 97 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.75474476 |
| 98 | defense response to protozoan (GO:0042832) | 2.73836851 |
| 99 | positive regulation of T cell cytokine production (GO:0002726) | 2.73640926 |
| 100 | negative regulation of innate immune response (GO:0045824) | 2.72530234 |
| 101 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.72044997 |
| 102 | modulation by symbiont of host cellular process (GO:0044068) | 2.71964877 |
| 103 | detection of biotic stimulus (GO:0009595) | 2.71513403 |
| 104 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.70776124 |
| 105 | regulation of antigen processing and presentation (GO:0002577) | 2.70155336 |
| 106 | regulation of interleukin-12 production (GO:0032655) | 2.69983831 |
| 107 | granulocyte activation (GO:0036230) | 2.69489228 |
| 108 | regulation of vitamin metabolic process (GO:0030656) | 2.69265813 |
| 109 | T cell selection (GO:0045058) | 2.69040132 |
| 110 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.69018083 |
| 111 | negative regulation of viral release from host cell (GO:1902187) | 2.68535731 |
| 112 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.68397166 |
| 113 | negative regulation of type I interferon production (GO:0032480) | 2.68098794 |
| 114 | response to interferon-gamma (GO:0034341) | 2.66520738 |
| 115 | lymphocyte chemotaxis (GO:0048247) | 2.66291610 |
| 116 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.64341032 |
| 117 | macrophage activation (GO:0042116) | 2.64312745 |
| 118 | response to host (GO:0075136) | 2.62901706 |
| 119 | response to host defenses (GO:0052200) | 2.62901706 |
| 120 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.62901706 |
| 121 | positive regulation of transcription factor import into nucleus (GO:0042993) | 2.61092557 |
| 122 | urea cycle (GO:0000050) | 2.60423388 |
| 123 | urea metabolic process (GO:0019627) | 2.60423388 |
| 124 | myeloid dendritic cell activation (GO:0001773) | 2.60400806 |
| 125 | low-density lipoprotein particle clearance (GO:0034383) | 2.60304860 |
| 126 | positive T cell selection (GO:0043368) | 2.60027760 |
| 127 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.58529468 |
| 128 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.58502706 |
| 129 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.56167457 |
| 130 | neutrophil activation involved in immune response (GO:0002283) | 2.54391334 |
| 131 | regulation of RIG-I signaling pathway (GO:0039535) | 2.54315634 |
| 132 | regulation of response to interferon-gamma (GO:0060330) | 2.54084908 |
| 133 | cytokine secretion (GO:0050663) | 2.54031875 |
| 134 | phospholipid efflux (GO:0033700) | 2.53987298 |
| 135 | cellular response to interferon-gamma (GO:0071346) | 2.52667068 |
| 136 | plasma lipoprotein particle clearance (GO:0034381) | 2.51533202 |
| 137 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.50903560 |
| 138 | regulation of superoxide anion generation (GO:0032928) | 2.50698691 |
| 139 | complement activation, alternative pathway (GO:0006957) | 2.48209400 |
| 140 | positive regulation of type 2 immune response (GO:0002830) | 2.48116423 |
| 141 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.47567376 |
| 142 | negative regulation of sterol transport (GO:0032372) | 2.46622449 |
| 143 | negative regulation of cholesterol transport (GO:0032375) | 2.46622449 |
| 144 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.45774911 |
| 145 | regulation of interferon-beta production (GO:0032648) | 2.45610586 |
| 146 | negative regulation of lipid storage (GO:0010888) | 2.44878218 |
| 147 | regulation of humoral immune response (GO:0002920) | 2.44868023 |
| 148 | positive regulation of lipid storage (GO:0010884) | 2.43672794 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.60248940 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.65391213 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.35679918 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.15375377 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.89045847 |
| 6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.85569905 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.69708136 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.19382343 |
| 9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.99258283 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.98888555 |
| 11 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.97486720 |
| 12 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.80171329 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.78604499 |
| 14 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.66513563 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.62456530 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.52525047 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.51600012 |
| 18 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.51217547 |
| 19 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.35409267 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.34846781 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.23212016 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.21960785 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.19754309 |
| 24 | MAF_26560356_Chip-Seq_TH1_Human | 2.16943991 |
| 25 | GATA1_22025678_ChIP-Seq_K562_Human | 2.14241598 |
| 26 | MYC_22102868_ChIP-Seq_BL_Human | 2.13916152 |
| 27 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.11687469 |
| 28 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.09974293 |
| 29 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.09236873 |
| 30 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.06255684 |
| 31 | MYB_26560356_Chip-Seq_TH1_Human | 1.94649928 |
| 32 | MYB_26560356_Chip-Seq_TH2_Human | 1.86607922 |
| 33 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.85350677 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.84637738 |
| 35 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.83191198 |
| 36 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.79726119 |
| 37 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.77166500 |
| 38 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.76045404 |
| 39 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.70593287 |
| 40 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.68767824 |
| 41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.67781404 |
| 42 | UTX_26944678_Chip-Seq_JUKART_Human | 1.65286365 |
| 43 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.64122640 |
| 44 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.63047388 |
| 45 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.61849313 |
| 46 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.60617881 |
| 47 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.59396018 |
| 48 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.57099054 |
| 49 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.55488586 |
| 50 | SPI1_23127762_ChIP-Seq_K562_Human | 1.51790715 |
| 51 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.51465346 |
| 52 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.50877314 |
| 53 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.50476065 |
| 54 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.47176162 |
| 55 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.44150237 |
| 56 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.41784441 |
| 57 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.41644544 |
| 58 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.39202337 |
| 59 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.38341814 |
| 60 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36657068 |
| 61 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.36040188 |
| 62 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.35791163 |
| 63 | KDM2B_26808549_Chip-Seq_K562_Human | 1.30520981 |
| 64 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.30298468 |
| 65 | MAF_26560356_Chip-Seq_TH2_Human | 1.30166767 |
| 66 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.25362208 |
| 67 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.24655781 |
| 68 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.24342497 |
| 69 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.21549795 |
| 70 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17244728 |
| 71 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.17031881 |
| 72 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15740565 |
| 73 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.13203946 |
| 74 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13127443 |
| 75 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.11322780 |
| 76 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10776869 |
| 77 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.10546573 |
| 78 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06289523 |
| 79 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.05335079 |
| 80 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.04460238 |
| 81 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04395970 |
| 82 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.04376013 |
| 83 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02359297 |
| 84 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.02309543 |
| 85 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.00446967 |
| 86 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.00439143 |
| 87 | GATA3_26560356_Chip-Seq_TH2_Human | 1.00303838 |
| 88 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98330933 |
| 89 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97756995 |
| 90 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97617880 |
| 91 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96609256 |
| 92 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95953735 |
| 93 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.95777776 |
| 94 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.95682412 |
| 95 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.95528288 |
| 96 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.95125142 |
| 97 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.95067166 |
| 98 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.94146049 |
| 99 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.93499179 |
| 100 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.91990814 |
| 101 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.91585217 |
| 102 | GATA2_19941826_ChIP-Seq_K562_Human | 0.90663462 |
| 103 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.89765082 |
| 104 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.89507549 |
| 105 | GATA1_19941826_ChIP-Seq_K562_Human | 0.89335337 |
| 106 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.89116626 |
| 107 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88614550 |
| 108 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.87187020 |
| 109 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83801979 |
| 110 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83358627 |
| 111 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.83050365 |
| 112 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.82620991 |
| 113 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82106697 |
| 114 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.80931764 |
| 115 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80801386 |
| 116 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.79066512 |
| 117 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.78164407 |
| 118 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77040390 |
| 119 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.76539499 |
| 120 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.75981891 |
| 121 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.75689041 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.87039589 |
| 2 | MP0001790_abnormal_immune_system | 3.35869345 |
| 3 | MP0005387_immune_system_phenotype | 3.35869345 |
| 4 | MP0000685_abnormal_immune_system | 3.19233739 |
| 5 | MP0003303_peritoneal_inflammation | 3.04219275 |
| 6 | MP0001800_abnormal_humoral_immune | 3.03734714 |
| 7 | MP0005360_urolithiasis | 3.00783354 |
| 8 | MP0002139_abnormal_hepatobiliary_system | 2.83714916 |
| 9 | MP0003436_decreased_susceptibility_to | 2.68040825 |
| 10 | MP0009785_altered_susceptibility_to | 2.63549258 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.52821836 |
| 12 | MP0002452_abnormal_antigen_presenting | 2.49688616 |
| 13 | MP0004510_myositis | 2.46356328 |
| 14 | MP0002723_abnormal_immune_serum | 2.37780984 |
| 15 | MP0005025_abnormal_response_to | 2.32853884 |
| 16 | MP0009840_abnormal_foam_cell | 2.22304218 |
| 17 | MP0005671_abnormal_response_to | 2.22255596 |
| 18 | MP0002419_abnormal_innate_immunity | 2.20592130 |
| 19 | MP0003300_gastrointestinal_ulcer | 2.17569334 |
| 20 | MP0004947_skin_inflammation | 2.11072942 |
| 21 | MP0000569_abnormal_digit_pigmentation | 2.10908554 |
| 22 | MP0002420_abnormal_adaptive_immunity | 2.06422899 |
| 23 | MP0001819_abnormal_immune_cell | 2.06294423 |
| 24 | MP0002138_abnormal_hepatobiliary_system | 2.03487070 |
| 25 | MP0005365_abnormal_bile_salt | 2.03187525 |
| 26 | MP0002166_altered_tumor_susceptibility | 1.93965580 |
| 27 | MP0005085_abnormal_gallbladder_physiolo | 1.90079233 |
| 28 | MP0002148_abnormal_hypersensitivity_rea | 1.89142382 |
| 29 | MP0009278_abnormal_bone_marrow | 1.80957960 |
| 30 | MP0002398_abnormal_bone_marrow | 1.76733237 |
| 31 | MP0005464_abnormal_platelet_physiology | 1.75192943 |
| 32 | MP0003724_increased_susceptibility_to | 1.73231561 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.72987159 |
| 34 | MP0003252_abnormal_bile_duct | 1.72149247 |
| 35 | MP0005083_abnormal_biliary_tract | 1.72061623 |
| 36 | MP0000716_abnormal_immune_system | 1.71047014 |
| 37 | MP0003191_abnormal_cellular_cholesterol | 1.69562324 |
| 38 | MP0003763_abnormal_thymus_physiology | 1.68052653 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.66608448 |
| 40 | MP0006082_CNS_inflammation | 1.66298059 |
| 41 | MP0001853_heart_inflammation | 1.61746625 |
| 42 | MP0008469_abnormal_protein_level | 1.60795634 |
| 43 | MP0002405_respiratory_system_inflammati | 1.58731630 |
| 44 | MP0000689_abnormal_spleen_morphology | 1.57097048 |
| 45 | MP0001873_stomach_inflammation | 1.55846081 |
| 46 | MP0008004_abnormal_stomach_pH | 1.55085956 |
| 47 | MP0002006_tumorigenesis | 1.51367648 |
| 48 | MP0008875_abnormal_xenobiotic_pharmacok | 1.46468644 |
| 49 | MP0000609_abnormal_liver_physiology | 1.44744835 |
| 50 | MP0009764_decreased_sensitivity_to | 1.44135600 |
| 51 | MP0002332_abnormal_exercise_endurance | 1.44038109 |
| 52 | MP0002429_abnormal_blood_cell | 1.38239063 |
| 53 | MP0005058_abnormal_lysosome_morphology | 1.36621017 |
| 54 | MP0002722_abnormal_immune_system | 1.36011881 |
| 55 | MP0002254_reproductive_system_inflammat | 1.35817307 |
| 56 | MP0001545_abnormal_hematopoietic_system | 1.34634116 |
| 57 | MP0005397_hematopoietic_system_phenotyp | 1.34634116 |
| 58 | MP0010329_abnormal_lipoprotein_level | 1.31269953 |
| 59 | MP0000604_amyloidosis | 1.28856798 |
| 60 | MP0001533_abnormal_skeleton_physiology | 1.26198306 |
| 61 | MP0003172_abnormal_lysosome_physiology | 1.23179190 |
| 62 | MP0003183_abnormal_peptide_metabolism | 1.22003606 |
| 63 | MP0009763_increased_sensitivity_to | 1.18635244 |
| 64 | MP0000343_altered_response_to | 1.17962585 |
| 65 | MP0003091_abnormal_cell_migration | 1.13927091 |
| 66 | MP0004808_abnormal_hematopoietic_stem | 1.10543450 |
| 67 | MP0001666_abnormal_nutrient_absorption | 1.05577768 |
| 68 | MP0003705_abnormal_hypodermis_morpholog | 1.05569714 |
| 69 | MP0005164_abnormal_response_to | 1.04927827 |
| 70 | MP0009333_abnormal_splenocyte_physiolog | 1.03576037 |
| 71 | MP0005390_skeleton_phenotype | 1.02372809 |
| 72 | MP0003448_altered_tumor_morphology | 1.02126892 |
| 73 | MP0005076_abnormal_cell_differentiation | 0.99476419 |
| 74 | MP0004381_abnormal_hair_follicle | 0.98710609 |
| 75 | MP0003566_abnormal_cell_adhesion | 0.98586705 |
| 76 | MP0005310_abnormal_salivary_gland | 0.98430874 |
| 77 | MP0003690_abnormal_glial_cell | 0.97640892 |
| 78 | MP0002396_abnormal_hematopoietic_system | 0.97167703 |
| 79 | MP0003453_abnormal_keratinocyte_physiol | 0.94670752 |
| 80 | MP0003866_abnormal_defecation | 0.94070644 |
| 81 | MP0000703_abnormal_thymus_morphology | 0.93356895 |
| 82 | MP0004883_abnormal_blood_vessel | 0.92992179 |
| 83 | MP0010352_gastrointestinal_tract_polyps | 0.92360623 |
| 84 | MP0005319_abnormal_enzyme/_coenzyme | 0.91256342 |
| 85 | MP0002933_joint_inflammation | 0.91004932 |
| 86 | MP0001851_eye_inflammation | 0.90633874 |
| 87 | MP0002877_abnormal_melanocyte_morpholog | 0.87848016 |
| 88 | MP0002136_abnormal_kidney_physiology | 0.87311895 |
| 89 | MP0000598_abnormal_liver_morphology | 0.87304423 |
| 90 | MP0001663_abnormal_digestive_system | 0.87238095 |
| 91 | MP0005023_abnormal_wound_healing | 0.87201815 |
| 92 | MP0003828_pulmonary_edema | 0.86219928 |
| 93 | MP0002928_abnormal_bile_duct | 0.84465568 |
| 94 | MP0001849_ear_inflammation | 0.84202496 |
| 95 | MP0002998_abnormal_bone_remodeling | 0.84137838 |
| 96 | MP0008260_abnormal_autophagy | 0.83679600 |
| 97 | MP0000465_gastrointestinal_hemorrhage | 0.83636653 |
| 98 | MP0003656_abnormal_erythrocyte_physiolo | 0.83102408 |
| 99 | MP0004858_abnormal_nervous_system | 0.83029609 |
| 100 | MP0010307_abnormal_tumor_latency | 0.82498933 |
| 101 | MP0005174_abnormal_tail_pigmentation | 0.82153189 |
| 102 | MP0002118_abnormal_lipid_homeostasis | 0.81403037 |
| 103 | MP0009765_abnormal_xenobiotic_induced | 0.81107100 |
| 104 | MP0000249_abnormal_blood_vessel | 0.79550103 |
| 105 | MP0000371_diluted_coat_color | 0.77682421 |
| 106 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.77286695 |
| 107 | MP0000767_abnormal_smooth_muscle | 0.74372063 |
| 108 | MP0009643_abnormal_urine_homeostasis | 0.74230508 |
| 109 | MP0005166_decreased_susceptibility_to | 0.73550046 |
| 110 | MP0001348_abnormal_lacrimal_gland | 0.73072796 |
| 111 | MP0005332_abnormal_amino_acid | 0.72980785 |
| 112 | MP0005666_abnormal_adipose_tissue | 0.72779580 |
| 113 | MP0003045_fibrosis | 0.72226636 |
| 114 | MP0000858_altered_metastatic_potential | 0.72061224 |
| 115 | MP0008874_decreased_physiological_sensi | 0.70791714 |
| 116 | MP0005167_abnormal_blood-brain_barrier | 0.69763082 |
| 117 | MP0008961_abnormal_basal_metabolism | 0.69706629 |
| 118 | MP0010234_abnormal_vibrissa_follicle | 0.68951423 |
| 119 | MP0003075_altered_response_to | 0.66057341 |
| 120 | MP0006054_spinal_hemorrhage | 0.66032381 |
| 121 | MP0001216_abnormal_epidermal_layer | 0.65569363 |
| 122 | MP0003795_abnormal_bone_structure | 0.65540152 |
| 123 | MP0004185_abnormal_adipocyte_glucose | 0.65379441 |
| 124 | MP0002796_impaired_skin_barrier | 0.65261286 |
| 125 | MP0005451_abnormal_body_composition | 0.62425498 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent viral infections (HP:0004429) | 4.06604158 |
| 2 | Autoimmune thrombocytopenia (HP:0001973) | 4.01729340 |
| 3 | Eczematoid dermatitis (HP:0000976) | 3.98677413 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 3.97173883 |
| 5 | Chronic otitis media (HP:0000389) | 3.93040607 |
| 6 | Colitis (HP:0002583) | 3.83167351 |
| 7 | Recurrent abscess formation (HP:0002722) | 3.82718325 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.81346473 |
| 9 | Vasculitis (HP:0002633) | 3.75267648 |
| 10 | Agammaglobulinemia (HP:0004432) | 3.69210401 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.63183547 |
| 12 | Recurrent bronchitis (HP:0002837) | 3.62179004 |
| 13 | Recurrent fungal infections (HP:0002841) | 3.57549021 |
| 14 | Myocardial infarction (HP:0001658) | 3.52712517 |
| 15 | Gastrointestinal stroma tumor (HP:0100723) | 3.52522276 |
| 16 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.35470839 |
| 17 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.35470839 |
| 18 | Abnormality of glycolipid metabolism (HP:0010969) | 3.35470839 |
| 19 | Mediastinal lymphadenopathy (HP:0100721) | 3.33822771 |
| 20 | Gingival bleeding (HP:0000225) | 3.23736914 |
| 21 | Inflammation of the large intestine (HP:0002037) | 3.20924425 |
| 22 | Myositis (HP:0100614) | 3.20843342 |
| 23 | Recurrent skin infections (HP:0001581) | 3.16957169 |
| 24 | Stomatitis (HP:0010280) | 3.16309826 |
| 25 | Loss of speech (HP:0002371) | 3.13418418 |
| 26 | Deep venous thrombosis (HP:0002625) | 3.13327376 |
| 27 | Mitral stenosis (HP:0001718) | 3.11322173 |
| 28 | Nasal polyposis (HP:0100582) | 3.09730678 |
| 29 | Gastrointestinal inflammation (HP:0004386) | 3.05156726 |
| 30 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.03795012 |
| 31 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.99971805 |
| 32 | Recurrent cutaneous fungal infections (HP:0011370) | 2.99971805 |
| 33 | Orchitis (HP:0100796) | 2.98844274 |
| 34 | Cellulitis (HP:0100658) | 2.98608714 |
| 35 | Pustule (HP:0200039) | 2.93802517 |
| 36 | Retrobulbar optic neuritis (HP:0100654) | 2.91259680 |
| 37 | Optic neuritis (HP:0100653) | 2.91259680 |
| 38 | Emphysema (HP:0002097) | 2.90878895 |
| 39 | Joint hemorrhage (HP:0005261) | 2.90018264 |
| 40 | Abnormality of the nasal mucosa (HP:0000433) | 2.86192586 |
| 41 | Periodontitis (HP:0000704) | 2.86014848 |
| 42 | Abnormality of the fingertips (HP:0001211) | 2.83760457 |
| 43 | Dysostosis multiplex (HP:0000943) | 2.79218266 |
| 44 | Xanthomatosis (HP:0000991) | 2.73198703 |
| 45 | Meningitis (HP:0001287) | 2.71630783 |
| 46 | Pulmonary infiltrates (HP:0002113) | 2.70965179 |
| 47 | Abnormality of macrophages (HP:0004311) | 2.68663329 |
| 48 | Arterial thrombosis (HP:0004420) | 2.65895583 |
| 49 | Hematochezia (HP:0002573) | 2.65129903 |
| 50 | Chronic obstructive pulmonary disease (HP:0006510) | 2.61877336 |
| 51 | Obstructive lung disease (HP:0006536) | 2.61877336 |
| 52 | Panhypogammaglobulinemia (HP:0003139) | 2.57959890 |
| 53 | Increased IgM level (HP:0003496) | 2.57648634 |
| 54 | Complement deficiency (HP:0004431) | 2.56148075 |
| 55 | Recurrent sinusitis (HP:0011108) | 2.54747204 |
| 56 | Intrahepatic cholestasis (HP:0001406) | 2.53934392 |
| 57 | Increased cerebral lipofuscin (HP:0011813) | 2.53621963 |
| 58 | Osteomyelitis (HP:0002754) | 2.52311569 |
| 59 | Gingivitis (HP:0000230) | 2.50243148 |
| 60 | Abnormality of T cell number (HP:0011839) | 2.48374479 |
| 61 | Increased IgE level (HP:0003212) | 2.46146445 |
| 62 | Spontaneous hematomas (HP:0007420) | 2.46031297 |
| 63 | Amyloidosis (HP:0011034) | 2.45064076 |
| 64 | T lymphocytopenia (HP:0005403) | 2.44333566 |
| 65 | Lymphopenia (HP:0001888) | 2.43772157 |
| 66 | Abnormality of the common coagulation pathway (HP:0010990) | 2.43409956 |
| 67 | Gangrene (HP:0100758) | 2.43027678 |
| 68 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.41349823 |
| 69 | IgA deficiency (HP:0002720) | 2.38808593 |
| 70 | Restrictive lung disease (HP:0002091) | 2.38711658 |
| 71 | Prolonged partial thromboplastin time (HP:0003645) | 2.37742644 |
| 72 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.37411769 |
| 73 | Chronic sinusitis (HP:0011109) | 2.37229431 |
| 74 | IgM deficiency (HP:0002850) | 2.35225791 |
| 75 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.32873807 |
| 76 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.32873807 |
| 77 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.32873807 |
| 78 | Gastrointestinal infarctions (HP:0005244) | 2.31366552 |
| 79 | Chronic diarrhea (HP:0002028) | 2.30279299 |
| 80 | Joint swelling (HP:0001386) | 2.28903588 |
| 81 | Epistaxis (HP:0000421) | 2.28038865 |
| 82 | Peritonitis (HP:0002586) | 2.26769829 |
| 83 | Interstitial pulmonary disease (HP:0006530) | 2.26166781 |
| 84 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.25917233 |
| 85 | Mucopolysacchariduria (HP:0008155) | 2.25698326 |
| 86 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.25698326 |
| 87 | Esophageal varix (HP:0002040) | 2.24872906 |
| 88 | Papilloma (HP:0012740) | 2.24612686 |
| 89 | Verrucae (HP:0200043) | 2.24612686 |
| 90 | Systemic lupus erythematosus (HP:0002725) | 2.24116197 |
| 91 | Thin bony cortex (HP:0002753) | 2.23552160 |
| 92 | Hypobetalipoproteinemia (HP:0003563) | 2.23539068 |
| 93 | Anorexia (HP:0002039) | 2.23273380 |
| 94 | Increased serum ferritin (HP:0003281) | 2.22169151 |
| 95 | Abnormality of the pericardium (HP:0001697) | 2.19005253 |
| 96 | Leukocytosis (HP:0001974) | 2.15599338 |
| 97 | Vacuolated lymphocytes (HP:0001922) | 2.14777283 |
| 98 | Abnormality of T cells (HP:0002843) | 2.14392793 |
| 99 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.13940499 |
| 100 | Thrombophlebitis (HP:0004418) | 2.11700958 |
| 101 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.11532296 |
| 102 | Abnormality of the pleura (HP:0002103) | 2.11519332 |
| 103 | Pulmonary embolism (HP:0002204) | 2.10668804 |
| 104 | Keratoconjunctivitis sicca (HP:0001097) | 2.09387504 |
| 105 | Abnormality of the endocardium (HP:0004306) | 2.07952223 |
| 106 | Hemoptysis (HP:0002105) | 2.07906887 |
| 107 | Hyperlipoproteinemia (HP:0010980) | 2.07865176 |
| 108 | Autoimmune hemolytic anemia (HP:0001890) | 2.06818854 |
| 109 | Malnutrition (HP:0004395) | 2.05520785 |
| 110 | Chest pain (HP:0100749) | 2.04650845 |
| 111 | Encephalitis (HP:0002383) | 2.03183517 |
| 112 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.03027808 |
| 113 | Osteolytic defects of the hand bones (HP:0009699) | 2.03027808 |
| 114 | Epidermoid cyst (HP:0200040) | 2.02288347 |
| 115 | Abnormality of complement system (HP:0005339) | 2.00651249 |
| 116 | Polycythemia (HP:0001901) | 2.00422887 |
| 117 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.99368045 |
| 118 | Abnormality of T cell physiology (HP:0011840) | 1.99348046 |
| 119 | Eosinophilia (HP:0001880) | 1.98708447 |
| 120 | Urticaria (HP:0001025) | 1.98555609 |
| 121 | Thick nail (HP:0001805) | 1.97448874 |
| 122 | Abnormal platelet volume (HP:0011876) | 1.94923347 |
| 123 | Broad face (HP:0000283) | 1.93584635 |
| 124 | Episodic fever (HP:0001954) | 1.93566433 |
| 125 | Arthralgia (HP:0002829) | 1.92639908 |
| 126 | Acne (HP:0001061) | 1.92593570 |
| 127 | Frequent falls (HP:0002359) | 1.92577190 |
| 128 | Hypercholesterolemia (HP:0003124) | 1.91681505 |
| 129 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.91592105 |
| 130 | Glomerulopathy (HP:0100820) | 1.89808430 |
| 131 | Premature loss of primary teeth (HP:0006323) | 1.89202067 |
| 132 | Hypergammaglobulinemia (HP:0010702) | 1.88907867 |
| 133 | Hemorrhage of the eye (HP:0011885) | 1.88586726 |
| 134 | Keratoconjunctivitis (HP:0001096) | 1.88486759 |
| 135 | Purpura (HP:0000979) | 1.86947552 |
| 136 | Sepsis (HP:0100806) | 1.86776732 |
| 137 | Polygenic inheritance (HP:0010982) | 1.85985478 |
| 138 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.85516014 |
| 139 | Keratitis (HP:0000491) | 1.81955750 |
| 140 | Cheilitis (HP:0100825) | 1.81709994 |
| 141 | Skin ulcer (HP:0200042) | 1.80489287 |
| 142 | Vertigo (HP:0002321) | 1.79009426 |
| 143 | Prolonged bleeding time (HP:0003010) | 1.78208331 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.31653938 |
| 2 | TYK2 | 3.91620031 |
| 3 | MAP3K14 | 3.85261652 |
| 4 | IKBKE | 3.04748579 |
| 5 | ERN1 | 3.01491452 |
| 6 | PRPF4B | 2.96918172 |
| 7 | MAP3K13 | 2.91930150 |
| 8 | JAK3 | 2.87994363 |
| 9 | JAK1 | 2.85272199 |
| 10 | TBK1 | 2.82627686 |
| 11 | FGFR4 | 2.80240129 |
| 12 | IRAK3 | 2.54717670 |
| 13 | MAP3K10 | 2.35445656 |
| 14 | RIPK4 | 2.10695331 |
| 15 | BLK | 1.94818476 |
| 16 | IKBKB | 1.93154970 |
| 17 | KIT | 1.91882328 |
| 18 | IRAK4 | 1.80157422 |
| 19 | TAOK2 | 1.80010127 |
| 20 | SIK1 | 1.75393965 |
| 21 | CDK12 | 1.65592503 |
| 22 | EPHB1 | 1.65508922 |
| 23 | TAOK3 | 1.64594420 |
| 24 | GRK6 | 1.59016221 |
| 25 | SMG1 | 1.58985342 |
| 26 | MAP3K11 | 1.58838950 |
| 27 | SIK2 | 1.57612443 |
| 28 | FGFR3 | 1.56607295 |
| 29 | CHUK | 1.53613344 |
| 30 | CSF1R | 1.49051629 |
| 31 | SYK | 1.46015596 |
| 32 | CDC42BPA | 1.45926404 |
| 33 | STK10 | 1.45572386 |
| 34 | ZAP70 | 1.45124306 |
| 35 | CSK | 1.44069270 |
| 36 | TXK | 1.39057367 |
| 37 | PTK6 | 1.37332101 |
| 38 | BTK | 1.34004429 |
| 39 | GRK7 | 1.30399404 |
| 40 | HCK | 1.27524473 |
| 41 | TTN | 1.27153292 |
| 42 | TRIB3 | 1.24823463 |
| 43 | DDR2 | 1.22805157 |
| 44 | TNK2 | 1.21807154 |
| 45 | EPHA3 | 1.19851875 |
| 46 | JAK2 | 1.19537079 |
| 47 | MARK3 | 1.12784670 |
| 48 | LCK | 1.11666565 |
| 49 | NME2 | 1.11652163 |
| 50 | IRAK2 | 1.09883507 |
| 51 | EPHA2 | 1.08297956 |
| 52 | LRRK2 | 1.05033941 |
| 53 | ITK | 1.04145796 |
| 54 | ICK | 1.01521759 |
| 55 | TGFBR2 | 0.98873783 |
| 56 | CAMK1D | 0.94556895 |
| 57 | PKN2 | 0.93396584 |
| 58 | PIM1 | 0.91603608 |
| 59 | MARK2 | 0.91140873 |
| 60 | PRKD2 | 0.91043751 |
| 61 | MAP3K7 | 0.84873616 |
| 62 | RPS6KA4 | 0.84695791 |
| 63 | FES | 0.82485147 |
| 64 | BMPR2 | 0.82048084 |
| 65 | LYN | 0.80879276 |
| 66 | CAMK1G | 0.80754972 |
| 67 | MAP2K3 | 0.77718432 |
| 68 | PRKCQ | 0.75212743 |
| 69 | SIK3 | 0.74370067 |
| 70 | RIPK1 | 0.69742606 |
| 71 | MOS | 0.68683067 |
| 72 | TEC | 0.68638683 |
| 73 | NEK9 | 0.66754960 |
| 74 | EEF2K | 0.66374078 |
| 75 | PIM2 | 0.63783741 |
| 76 | EGFR | 0.60825884 |
| 77 | MAP3K6 | 0.60251427 |
| 78 | MST1R | 0.59840833 |
| 79 | FGR | 0.59161719 |
| 80 | PDGFRA | 0.58932918 |
| 81 | NLK | 0.57890633 |
| 82 | MAPK11 | 0.55850171 |
| 83 | RPS6KA2 | 0.54284850 |
| 84 | RPS6KL1 | 0.53857056 |
| 85 | RPS6KC1 | 0.53857056 |
| 86 | ABL1 | 0.53111176 |
| 87 | CDK6 | 0.52345007 |
| 88 | FLT3 | 0.52325803 |
| 89 | KDR | 0.52202501 |
| 90 | KSR2 | 0.51576327 |
| 91 | SGK3 | 0.50481866 |
| 92 | TESK2 | 0.49694651 |
| 93 | TYRO3 | 0.49179776 |
| 94 | PRKCH | 0.48381063 |
| 95 | BRD4 | 0.46037073 |
| 96 | DAPK2 | 0.46022326 |
| 97 | PDK1 | 0.45332672 |
| 98 | PRKAA2 | 0.44796116 |
| 99 | PAK4 | 0.44581492 |
| 100 | MTOR | 0.44479774 |
| 101 | CDK4 | 0.43023028 |
| 102 | PDGFRB | 0.42904763 |
| 103 | MAP3K3 | 0.42663131 |
| 104 | IRAK1 | 0.42597483 |
| 105 | STK4 | 0.42566565 |
| 106 | RPS6KA6 | 0.42530761 |
| 107 | BMX | 0.41598401 |
| 108 | HIPK2 | 0.41514010 |
| 109 | MAP2K6 | 0.41211762 |
| 110 | MAP3K5 | 0.40731011 |
| 111 | PKN1 | 0.40522823 |
| 112 | MAPKAPK2 | 0.37578364 |
| 113 | ALK | 0.36544743 |
| 114 | STK3 | 0.34047521 |
| 115 | PDPK1 | 0.33288833 |
| 116 | CLK1 | 0.33277321 |
| 117 | INSR | 0.31986782 |
| 118 | MST4 | 0.31973301 |
| 119 | MAPK7 | 0.31924158 |
| 120 | MAP2K2 | 0.29061674 |
| 121 | MAPK4 | 0.27903092 |
| 122 | FYN | 0.27617168 |
| 123 | MELK | 0.27346080 |
| 124 | TRPM7 | 0.26593780 |
| 125 | MATK | 0.26296045 |
| 126 | MAPK12 | 0.26219253 |
| 127 | PRKCD | 0.21362264 |
| 128 | MAP3K1 | 0.21313424 |
| 129 | DYRK1B | 0.20656773 |
| 130 | TAOK1 | 0.20305088 |
| 131 | GSK3A | 0.19252846 |
| 132 | MAPK3 | 0.19243546 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.86557878 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.71801379 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.68602827 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.59000146 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.46185267 |
| 6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.30527795 |
| 7 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.28996710 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.24067855 |
| 9 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.23865856 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.17664119 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.09960714 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.08729454 |
| 13 | Other glycan degradation_Homo sapiens_hsa00511 | 2.00578293 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.92716079 |
| 15 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.89843180 |
| 16 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.89587454 |
| 17 | Influenza A_Homo sapiens_hsa05164 | 1.82943275 |
| 18 | Allograft rejection_Homo sapiens_hsa05330 | 1.69725369 |
| 19 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.61778334 |
| 20 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.60584894 |
| 21 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.55321508 |
| 22 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.53220892 |
| 23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.52324676 |
| 24 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.52165539 |
| 25 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.52057362 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.44925005 |
| 27 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.44808582 |
| 28 | Malaria_Homo sapiens_hsa05144 | 1.40636581 |
| 29 | Hepatitis C_Homo sapiens_hsa05160 | 1.40311572 |
| 30 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.38521918 |
| 31 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.37973542 |
| 32 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.36289713 |
| 33 | Tuberculosis_Homo sapiens_hsa05152 | 1.33309221 |
| 34 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.31207324 |
| 35 | Pertussis_Homo sapiens_hsa05133 | 1.28055032 |
| 36 | ABC transporters_Homo sapiens_hsa02010 | 1.27162721 |
| 37 | Lysine degradation_Homo sapiens_hsa00310 | 1.19491088 |
| 38 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.18568808 |
| 39 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.14350247 |
| 40 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.14020671 |
| 41 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.13751543 |
| 42 | Legionellosis_Homo sapiens_hsa05134 | 1.13422593 |
| 43 | Apoptosis_Homo sapiens_hsa04210 | 1.12802204 |
| 44 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.12135212 |
| 45 | Hepatitis B_Homo sapiens_hsa05161 | 1.11807545 |
| 46 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.09699566 |
| 47 | Lysosome_Homo sapiens_hsa04142 | 1.09409428 |
| 48 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.08111363 |
| 49 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.05276399 |
| 50 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.03854284 |
| 51 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.01749964 |
| 52 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.99600793 |
| 53 | Insulin resistance_Homo sapiens_hsa04931 | 0.98487755 |
| 54 | Viral myocarditis_Homo sapiens_hsa05416 | 0.95048326 |
| 55 | Bladder cancer_Homo sapiens_hsa05219 | 0.94790151 |
| 56 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.93155941 |
| 57 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.93115645 |
| 58 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.89998527 |
| 59 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.89222927 |
| 60 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.85668635 |
| 61 | Phagosome_Homo sapiens_hsa04145 | 0.85161691 |
| 62 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.84032975 |
| 63 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.81698494 |
| 64 | Shigellosis_Homo sapiens_hsa05131 | 0.81203352 |
| 65 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.80646174 |
| 66 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.80071246 |
| 67 | Prion diseases_Homo sapiens_hsa05020 | 0.79544152 |
| 68 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.77013777 |
| 69 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.76696658 |
| 70 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.72813030 |
| 71 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.69837280 |
| 72 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.69456862 |
| 73 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.68871867 |
| 74 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.66922771 |
| 75 | Histidine metabolism_Homo sapiens_hsa00340 | 0.66665454 |
| 76 | Peroxisome_Homo sapiens_hsa04146 | 0.65565476 |
| 77 | Asthma_Homo sapiens_hsa05310 | 0.63822073 |
| 78 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.62913141 |
| 79 | Bile secretion_Homo sapiens_hsa04976 | 0.62317152 |
| 80 | HTLV-I infection_Homo sapiens_hsa05166 | 0.61510332 |
| 81 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.61148931 |
| 82 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60864501 |
| 83 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.59995979 |
| 84 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.59749928 |
| 85 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56972343 |
| 86 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.56597101 |
| 87 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.56222454 |
| 88 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.56212233 |
| 89 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.55541775 |
| 90 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.55164218 |
| 91 | Endometrial cancer_Homo sapiens_hsa05213 | 0.54474363 |
| 92 | Endocytosis_Homo sapiens_hsa04144 | 0.53090260 |
| 93 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.52788884 |
| 94 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51689717 |
| 95 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.51040883 |
| 96 | Platelet activation_Homo sapiens_hsa04611 | 0.50772401 |
| 97 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50171824 |
| 98 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.49765623 |
| 99 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49363932 |
| 100 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.48420335 |
| 101 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.47873256 |
| 102 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.47752861 |
| 103 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.47628917 |
| 104 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.47526188 |
| 105 | Salmonella infection_Homo sapiens_hsa05132 | 0.47517054 |
| 106 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47387558 |
| 107 | Amoebiasis_Homo sapiens_hsa05146 | 0.46811390 |
| 108 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.46664618 |
| 109 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.45676397 |
| 110 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.43972918 |
| 111 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.43923235 |
| 112 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.43142345 |
| 113 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.42288453 |
| 114 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.42025597 |
| 115 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.41919435 |
| 116 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.41203759 |
| 117 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.41190619 |
| 118 | Prostate cancer_Homo sapiens_hsa05215 | 0.41056010 |
| 119 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.40120656 |
| 120 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.39971526 |
| 121 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.39957791 |
| 122 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.37647300 |
| 123 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.37555629 |
| 124 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.36944478 |
| 125 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.36221662 |
| 126 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.35662125 |
| 127 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.34910743 |
| 128 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.34718885 |
| 129 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.34604469 |
| 130 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.34497535 |
| 131 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.33771338 |
| 132 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.33346387 |
| 133 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.32896274 |
| 134 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.32313636 |
| 135 | Galactose metabolism_Homo sapiens_hsa00052 | 0.32100278 |

